Safety of inhaled levodopa by incidence and severity of treatment-related cough and throat irritation in people with Parkinson disease: Post hoc analysis of pooled data from three phase III trials

Inbrija (levodopa inhalation powder) - Merz Pharma

Astrid Scheschonka 1; Margaret Ngure 2; Carmen Walter 2; Selena Freisens 2; Georg Comes 2

Jun 2, 2026